Show simple item record

dc.contributor.authorBenjamin, Clara
dc.contributor.authorBryant, Maya
dc.contributor.authorTran, Tri
dc.contributor.authorAtalay, Rediet T
dc.contributor.authorAyele, Girma M
dc.contributor.authorMichael, Miriam B
dc.date.accessioned2022-08-05T11:38:28Z
dc.date.available2022-08-05T11:38:28Z
dc.date.issued2022-07-01
dc.identifier.urihttp://hdl.handle.net/10713/19517
dc.description.abstractSplenic vein thrombosis (SVT) is a well-recognized complication of acute and chronic pancreatitis. It is associated with complications of significant gastrointestinal bleeding and high morbidity if the thrombus propagates. There is a need to consider several factors in choosing whether to anticoagulate the patient. We report a case of SVT in a patient with a previous history of pancreatitis who presented with abdominal pain, nausea, and vomiting to the hospital. At the hospital, a CT scan revealed SVT. This case highlights the importance of undergoing further studies regarding anticoagulation for treating SVT in patients at risk for gastrointestinal bleeding.en_US
dc.description.urihttps://doi.org/10.7759/cureus.26488en_US
dc.language.isoenen_US
dc.publisherCureus, Inc.en_US
dc.relation.ispartofCureusen_US
dc.rightsCopyright © 2022, Benjamin et al.en_US
dc.subjectalcoholen_US
dc.subjectanticoagulationen_US
dc.subjectgastrointestinal bleedingen_US
dc.subjectpancreatitisen_US
dc.subjectsplenic vein thrombosisen_US
dc.titleThe Need to Anticoagulate Patients With Splenic Vein Thrombosis.en_US
dc.typeArticleen_US
dc.identifier.doi10.7759/cureus.26488
dc.identifier.pmid35919214
dc.source.journaltitleCureus
dc.source.volume14
dc.source.issue7
dc.source.beginpagee26488
dc.source.endpage
dc.source.countryUnited States


This item appears in the following Collection(s)

Show simple item record